Cargando…
A Case Report of Primary Pericardial Malignant Mesothelioma Treated with Pemetrexed and Cisplatin
Primary pericardial malignant mesothelioma (PPM) is a very rare malignancy, with an incidence of less than 0.002% and represents less than 5% of all mesotheliomas. The cause of pericardial mesothelioma is uncertain that differ from pleural mesothelioma which is associated with asbestos exposure. Thi...
Autores principales: | Kim, Jung Sun, Lim, Sang Yup, Hwang, Jinwook, Kang, Eun Joo, Choi, Yoon Ji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Academy of Medical Sciences
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5639073/ https://www.ncbi.nlm.nih.gov/pubmed/28960045 http://dx.doi.org/10.3346/jkms.2017.32.11.1879 |
Ejemplares similares
-
Review of pemetrexed in combination with cisplatin for the treatment of malignant pleural mesothelioma
por: Goudar, Ranjit K
Publicado: (2008) -
Primary Malignant Pericardial Mesothelioma Presenting as Acute Pericarditis
por: Choi, Won-Suk, et al.
Publicado: (2012) -
Co-existing pericardial and pleural malignant mesothelioma responding well to nedaplatin and pemetrexed: a case report
por: Wu, Mindan, et al.
Publicado: (2023) -
Adjuvant Bidirectional Chemotherapy with Intraperitoneal Pemetrexed Combined with Intravenous Cisplatin for Diffuse Malignant Peritoneal Mesothelioma
por: Bijelic, Lana, et al.
Publicado: (2012) -
In Vitro Characterization of Cisplatin and Pemetrexed Effects in Malignant Pleural Mesothelioma 3D Culture Phenotypes
por: Papazoglou, Eleftherios D., et al.
Publicado: (2019)